COVID-19: Small-Molecule Clinical Trials Landscape

Curr Top Med Chem. 2020;20(18):1577-1580. doi: 10.2174/156802662018200703154334.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Betacoronavirus / drug effects
  • Betacoronavirus / immunology
  • Betacoronavirus / pathogenicity*
  • COVID-19
  • COVID-19 Vaccines
  • China / epidemiology
  • Clinical Trials as Topic
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / epidemiology*
  • Coronavirus Infections / immunology
  • Coronavirus Infections / prevention & control
  • Drug Repositioning / trends
  • Europe / epidemiology
  • Humans
  • Pandemics / prevention & control
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / epidemiology*
  • Pneumonia, Viral / immunology
  • Pneumonia, Viral / prevention & control
  • Registries*
  • SARS-CoV-2
  • Small Molecule Libraries / therapeutic use*
  • United States / epidemiology
  • Viral Vaccines / biosynthesis

Substances

  • Antiviral Agents
  • COVID-19 Vaccines
  • Small Molecule Libraries
  • Viral Vaccines